Delivery Order SPE2DR25D3201-SPE2DR26FT4WE
- Not listed
- The Defense Logistics Agency awarded a $11,356.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for 120 tablets of Yonsa 125 mg on September 16, 2025, with an ultimate completion date of October 7, 2025. This non-competitive delivery order was placed against AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The performance location is AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,628.16 to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120 count) with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a $2,271.36 delivery order to AmerisourceBergen Drug Corp for Yonsa 125 mg tablets (120-count supply) with an ultimate completion date of September 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger federal contract vehicle. The product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a $2,271.36 delivery order to AmerisourceBergen Drug Corp for 120 tablets of Yonsa 125 mg on June 4, 2025, with completion expected by June 26, 2025. This firm fixed-price contract is a non-competitive child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,271.36 to AmerisourceBergen Drug Corp for 120 tablets of Yonsa 125 mg on July 21, 2025, with completion scheduled for August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Yonsa (abiraterone acetate) is a specialized pharmaceutical used in the treatment of prostate cancer, reflecting...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120-count units) under a firm fixed-price contract. The delivery order, valued at $2,393.67, was awarded on December 1, 2025, with an ultimate completion date of December 22, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120-count units) valued at $4,542.72, with an ultimate completion date of November 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child order under AmerisourceBergen's larger pharmaceutical supply vehicle. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $4,787.34 delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Yonsa 125 mg tablets (120-count). This is a non-set-aside, competitively awarded contract with firm fixed pricing and a completion date of December 19, 2025. The pharmaceutical will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,271.36 to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120-count) with an ultimate completion date of September 3, 2025. This non-set-aside contract employs firm fixed pricing and identifies Conshohocken, Pennsylvania as the place of performance. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor headquartered in Pennsylvania, fulfills this order...
- The Defense Logistics Agency awarded a delivery order valued at $2,393.67 to AmerisourceBergen Drug Corp for YONSA 125 mg tablets (120-count supply). This is a firm fixed-price, non-set-aside delivery order issued on November 4, 2025, with an ultimate completion date of November 26, 2025. YONSA is a prescription medication used in oncology treatment, and the order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT4WEDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,787.34 to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120-count units) with a completion date of January 14, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Yonsa is a prescription medication used in oncology treatment, reflecting the federal government's ongoing need for specialized pharmaceutical products to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement running through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs. AmerisourceBergen Drug Corp's continued awards under this vehicle demonstrate its established capability to meet federal procurement standards through open competition and position it as a critical supplier within DLA's medical supply chain serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 12/21/25 |